Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 350.00
Bid: 331.00
Ask: 350.00
Change: 13.00 (3.86%)
Spread: 19.00 (5.74%)
Open: 340.00
High: 350.00
Low: 340.00
Prev. Close: 337.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funds Under Management - Trading Update

21 Apr 2020 07:00

RNS Number : 2585K
City of London Investment Group PLC
21 April 2020
 



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Group" or "the Company")

 

FUNDS UNDER MANAGEMENT AS AT 31 March 2020,

TRADING UPDATE

 

City of London (LSE: CLIG), a leading specialist asset management group offering a range of institutional products investing in closed-end funds, announces that as at 31 March 2020, FuM were US$4.4 billion (£3.6 billion). This compares with US$6 billion (£4.5 billion) as at 31 December 2019. A breakdown by strategy follows:

 

FuM ($mn)

Strategy Index

Mar-20

Dec-19

%

Net

%

(estimate)

inc/dec

Flows

inc/dec

EM

3,237

4,429

-27%

(68)

MSCI EM

-24%

DEV

774

1,109

-30%

(5)

MSCI ACWI xUS

-23%

Opportunistic Value

231

270

-14%

30

ACWI/Barclays Global Agg

-11%

Frontier

153

206

-26%

8

MSCI Frontier

-27%

4,395

6,014

(35)

 Excludes seed investments

 

All strategies underperformed over the period due primarily to closed-end fund discount widening and, to a lesser extent, NAV underperformance. This was particularly acute during March in the immediate aftermath of the economic dislocation caused by COVID-19, which prompted selling pressure across all asset classes.

 

During the period under review, the Opportunistic Value and Developed strategies recorded combined net inflows of $25 million. The Frontier strategy saw net inflows of $8 million while the EM strategies saw net outflows of $68 million.

 

With regard to business development, the Group continues to maintain an active pipeline across all of its major CEF offerings with an increased interest in the diversification CEF strategies. 

 

Operations

 

Due to the COVID-19 pandemic, our business continuity plan was enabled with all staff working remotely via audio and secure video communication and full network connectivity to all critical systems with security protocols in place to protect client data.

 

The Group's income remains accrued at a weighted average rate of approximately 75 basis points of FuM, net of third party commissions and has not changed as a consequence of the COVID-19 outbreak.

 

Dividend

 

In recognition of the challenges posed by the COVID-19 pandemic, the Board continues to monitor closely the Group's financial position. Shareholders will be aware that your Board has always ensured the Company maintain a strong balance sheet with significant cash reserves and zero debt as we believe this policy provides a vital financial cushion to weather unforeseen events and market volatility such as that presented by COVID-19. Since it is impossible to know the duration of the current dislocation to economies and stock markets, it would be imprudent at this stage to make any statement regarding the final dividend in respect of the year to 30 June 2020. However, your Board is cognisant of the importance of dividends to our shareholders and will review the position after the year-end.

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Tom Griffith, CEO

City of London Investment Group PLC

Tel: 001-610-380-0435

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUQPCUPUGQU
Date   Source Headline
18th Sep 20177:00 amRNSFinal Results
8th Sep 20177:53 amRNSDirector/PDMR Shareholding
31st Aug 20174:00 pmRNSOpen letter to the board of icapital.biz Berhad
20th Jul 20176:22 pmRNSHolding(s) in Company
19th Jul 20177:00 amRNSTrading Update
13th Jul 20176:15 pmRNSHolding(s) in Company
13th Jul 20177:00 amRNSChange of announcement date
13th Jun 20174:26 pmRNSBoard Changes
26th May 20173:49 pmRNSDirector/PDMR Shareholding
25th May 20172:12 pmRNSDirector/PDMR Shareholding
22nd May 201712:56 pmRNSHolding(s) in Company
8th May 20176:03 pmRNSShare Buyback and Total Voting Rights
26th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20171:56 pmRNSDirector/PDMR Shareholding
11th Apr 20177:00 amRNSTrading Update
3rd Apr 201712:42 pmRNSHolding(s) in Company
24th Mar 20172:28 pmRNSHolding(s) in Company
21st Mar 20175:20 pmRNSHolding(s) in Company
22nd Feb 20171:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20171:37 pmRNSDirector/PDMR Shareholding
20th Feb 20177:46 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2016
24th Jan 20173:24 pmRNSHardman Research:Q2 statement robust profitability
17th Jan 20177:00 amRNSFunds Under Management - Trading Update
24th Nov 20163:42 pmRNSDirector/PDMR Shareholding
19th Oct 201611:15 amRNSAGM resolutions
17th Oct 20165:49 pmRNSResult of AGM
13th Oct 20163:05 pmRNSDirector/PDMR Shareholding
11th Oct 20165:13 pmRNSHolding(s) in Company
11th Oct 20162:51 pmRNSDirector/PDMR Shareholding
10th Oct 20167:46 amRNSAGM Trading Update - 1st Qtr Funds under Mgmt
15th Sep 20169:46 amRNSLetter to icapital.biz Berhad
14th Sep 20169:32 amRNSHardman Report: Exchange rate moves give big boost
12th Sep 20167:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2016
18th Jul 20167:00 amRNSTrading Update
1st Jul 20167:00 amRNSBlock listing cancellation & block listing return
30th Jun 20164:40 pmRNSSecond Price Monitoring Extn
30th Jun 20164:35 pmRNSPrice Monitoring Extension
23rd Jun 20165:55 pmRNSDirector/PDMR Shareholding
14th Apr 201612:38 pmRNSHardman & Co Issues Research Report
22nd Feb 201611:18 amRNSDirector/PDMR Shareholding
15th Feb 20167:00 amRNSHalf Yearly Report
5th Feb 20164:40 pmRNSSecond Price Monitoring Extn
5th Feb 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:41 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
27th Jan 20164:40 pmRNSSecond Price Monitoring Extn
27th Jan 20164:35 pmRNSPrice Monitoring Extension
13th Jan 20169:57 amRNSHardman Issues Research Report
12th Jan 20167:00 amRNSTrading Update
4th Jan 20169:55 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.